Query

Active Filters

  • (-) PSI Laboratories = Center for Proton Therapy CPT
Search Results 1 - 20 of 459

Pages

  • RSS Feed
Select Page
Evaluation of treatment-associated eye toxicity after irradiation in childhood and adolescence - results from the Registry of the Evaluation of Side Effects after Radiotherapy in Childhood and Adolescence (RiSK)
Albrecht, F., Wolters, H., Ziert, Y., Timmermann, B., Kortmann, R. D., Matuschek, C., … Steinmann, D. (2021). Evaluation of treatment-associated eye toxicity after irradiation in childhood and adolescence - results from the Registry of the Evaluation of Side Effects after Radiotherapy in Childhood and Adolescence (RiSK). Strahlentherapie und Onkologie, 197, 700-710. https://doi.org/10.1007/s00066-021-01793-2
An approach for estimating dosimetric uncertainties in deformable dose accumulation in pencil beam scanning proton therapy for lung cancer
Amstutz, F., Nenoff, L., Albertini, F., Ribeiro, C. O., Knopf, A. C., Unkelbach, J., … Zhang, Y. (2021). An approach for estimating dosimetric uncertainties in deformable dose accumulation in pencil beam scanning proton therapy for lung cancer. Physics in Medicine and Biology, 66(10), 105007 (12 pp.). https://doi.org/10.1088/1361-6560/abf8f5
Comparison of weekly and daily online adaptation for head and neck intensity-modulated proton therapy
Bobić, M., Lalonde, A., Sharp, G. C., Grassberger, C., Verburg, J. M., Winey, B. A., … Paganetti, H. (2021). Comparison of weekly and daily online adaptation for head and neck intensity-modulated proton therapy. Physics in Medicine and Biology, 66(5), 055023 (11 pp.). https://doi.org/10.1088/1361-6560/abe050
Al<sub>2</sub>O<sub>3</sub>:C optically stimulated luminescence dosimeters (OSLDs) for ultra-high dose rate proton dosimetry
Christensen, J. B., Togno, M., Nesteruk, K. P., Psoroulas, S., Meer, D., Weber, D. C., … Safai, S. (2021). Al2O3:C optically stimulated luminescence dosimeters (OSLDs) for ultra-high dose rate proton dosimetry. Physics in Medicine and Biology, 66(8), 085003 (11 pp.). https://doi.org/10.1088/1361-6560/abe554
ESTRO ACROP guideline for target volume delineation of skull base tumors
Combs, S. E., Baumert, B. G., Bendszus, M., Bozzao, A., Brada, M., Fariselli, L., … Minniti, G. (2021). ESTRO ACROP guideline for target volume delineation of skull base tumors. Radiotherapy and Oncology, 156, 80-94. https://doi.org/10.1016/j.radonc.2020.11.014
Clinical practice vs. state-of-the-art research and future visions: report on the 4D treatment planning workshop for particle therapy - edition 2018 and 2019
Czerska, K., Emert, F., Kopec, R., Langen, K., McClelland, J. R., Meijers, A., … Rucinski, A. (2021). Clinical practice vs. state-of-the-art research and future visions: report on the 4D treatment planning workshop for particle therapy - edition 2018 and 2019. Physica Medica, 82, 54-63. https://doi.org/10.1016/j.ejmp.2020.12.013
Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma. First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
Dietzsch, S., Braesigk, A., Seidel, C., Remmele, J., Kitzing, R., Schlender, T., … Kortmann, R. D. (2021). Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma. First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial. Strahlentherapie und Onkologie, 197, 674-682. https://doi.org/10.1007/s00066-020-01707-8
Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German radiotherapy quality control panel in the SIOP PNET5 MB trial
Dietzsch, S., Braesigk, A., Seidel, C., Remmele, J., Kitzing, R., Schlender, T., … Kortmann, R. D. (2021). Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German radiotherapy quality control panel in the SIOP PNET5 MB trial. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-021-01822-0
Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology
Eekers, D. B. P., Di Perri, D., Roelofs, E., Postma, A., Dijkstra, J., Ajithkumar, T., … Troost, E. G. C. (2021). Update of the EPTN atlas for CT- and MR-based contouring in Neuro-Oncology. Radiotherapy and Oncology, 160, 259-265. https://doi.org/10.1016/j.radonc.2021.05.013
Development and validation of a new set-up simulator dedicated to ocular proton therapy at CNAO
Elisei, G., Pella, A., Ricotti, R., Via, R., Fiore, M. R., Calvi, G., … Baroni, G. (2021). Development and validation of a new set-up simulator dedicated to ocular proton therapy at CNAO. Physica Medica, 82, 228-239. https://doi.org/10.1016/j.ejmp.2021.01.070
Enhanced-deep-inspiration breath hold superior to high-frequency percussive ventilation for respiratory motion mitigation: a physiology-driven, MRI-guided assessment towards optimized lung cancer treatment with proton therapy
Emert, F., Missimer, J., Eichenberger, P. A., Walser, M., Gmür, C., Lomax, A. J., … Spengler, C. M. (2021). Enhanced-deep-inspiration breath hold superior to high-frequency percussive ventilation for respiratory motion mitigation: a physiology-driven, MRI-guided assessment towards optimized lung cancer treatment with proton therapy. Frontiers in Oncology, 11, 621350 (17 pp.). https://doi.org/10.3389/fonc.2021.621350
Vestibular dose correlates with dizziness after radiosurgery for the treatment of vestibular schwannoma
Ermiş, E., Anschuetz, L., Leiser, D., Poel, R., Raabe, A., Manser, P., … Herrmann, E. (2021). Vestibular dose correlates with dizziness after radiosurgery for the treatment of vestibular schwannoma. Radiation Oncology, 16(1), 61 (10 pp.). https://doi.org/10.1186/s13014-021-01793-7
Technical assessment of the NDI Polaris Vega optical tracking system
Fattori, G., Lomax, A. J., Weber, D. C., & Safai, S. (2021). Technical assessment of the NDI Polaris Vega optical tracking system. Radiation Oncology, 16(1), 87 (4 pp.). https://doi.org/10.1186/s13014-021-01804-7
Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison
Fleury, E., Trnková, P., Spruijt, K., Herault, J., Lebbink, F., Heufelder, J., … Hoogeman, M. (2021). Characterization of the HollandPTC proton therapy beamline dedicated to uveal melanoma treatment and an interinstitutional comparison. Medical Physics, 48(8), 4506-4522. https://doi.org/10.1002/mp.15024
Stereotactic body radiotherapy for high‐risk prostate cancer: A systematic review
Foerster, R., Zwahlen, D. R., Buchali, A., Tang, H., Schroeder, C., Windisch, P., … Murthy, V. (2021). Stereotactic body radiotherapy for high‐risk prostate cancer: A systematic review. Cancers, 13(4), 759 (16 pp.). https://doi.org/10.3390/cancers13040759
Combining rescanning and gating for a time-efficient treatment of mobile tumors using pencil beam scanning proton therapy
Gut, P., Krieger, M., Lomax, T., Weber, D. C., & Hrbacek, J. (2021). Combining rescanning and gating for a time-efficient treatment of mobile tumors using pencil beam scanning proton therapy. Radiotherapy and Oncology, 160, 82-89. https://doi.org/10.1016/j.radonc.2021.03.041
Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives
Hua, Cho, Mascia, A. E., Seravalli, E., Lomax, A. J., Seiersen, K., & Ulin, K. (2021). Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives. Pediatric Blood & Cancer, 68(Suppl. 2), e28344 (9 pp.). https://doi.org/10.1002/pbc.28344
Liver-ultrasound-guided lung tumour tracking for scanned proton therapy: a feasibility study
Krieger, M., Giger, A., Jud, C., Duetschler, A., Salomir, R., Bieri, O., … Zhang, Y. (2021). Liver-ultrasound-guided lung tumour tracking for scanned proton therapy: a feasibility study. Physics in Medicine and Biology, 66(3), 035011 (14 pp.). https://doi.org/10.1088/1361-6560/abcde6
Malignancy rate of indeterminate findings on FDG-PET/CT in cutaneous melanoma patients
Kudura, K., Dimitriou, F., Mihic-Probst, D., Muehlematter, U. J., Kutzker, T., Basler, L., … Kreissl, M. C. (2021). Malignancy rate of indeterminate findings on FDG-PET/CT in cutaneous melanoma patients. Diagnostics, 11(5), 883 (14 pp.). https://doi.org/10.3390/diagnostics11050883
Prediction of early response to immune checkpoint inhibition using FDG-PET/CT in melanoma patients
Kudura, K., Dimitriou, F., Basler, L., Förster, R., Mihic-Probst, D., Kutzker, T., … Kreissl, M. C. (2021). Prediction of early response to immune checkpoint inhibition using FDG-PET/CT in melanoma patients. Cancers, 13(15), 3830 (16 pp.). https://doi.org/10.3390/cancers13153830
 

Pages